Peter has worked in the pharmaceutical and health care sectors for over 25 years. He has held both scientific and management positions in a number of blue-chip companies, most recently as Associate Director CMC in AstraZeneca's Antibiotics Business Unit. After 20 years in pharmaceutical development he set up a chemistry, manufacturing and control consultancy, Canta CMC Solutions Limited, with the aim of providing advice and support to companies and organisations going through the drug development process.

Peter joined the NW Region Analytical Division Committee in 2002 and has previously held the posts of Vice-Chair and Chair. He is currently the Honorary Treasurer.

e-mail:peter.doyle@cantacmcsolutions.com